Properties		Conclusion
CMR	Carcinogenicity (C)	Quinolin‐8‐ol is not considered to be a carcinogen according to point 3.6.3 of Annex II of Regulation (EC) No 1107/2009
	Mutagenicity (M)	Quinolin‐8‐ol is not considered to be a mutagen according to point 3.6.2 of Annex II of Regulation (EC) No 1107/2009
	Toxic for Reproduction (R)	Quinolin‐8‐ol has a harmonised classification as Reproductive toxicant category 1B (H360D ‘may damage the unborn child’) according to Regulation (EC) No 1272/2008 (ATP10–[4/5/2017])
Endocrine disrupting properties		Quinolin‐8‐ol is not considered to meet the criteria for endocrine disruption for human health and non‐target organisms according to points 3.6.5 and 3.8.2 of Annex II of Regulation No 1107/2009, as amended by Commission Regulation (EU) 2018/605
POP	Persistence	Quinolin‐8‐ol is not considered to be a persistent organic pollutant (POP) according to point 3.7.1 of Annex II of Regulation (EC) 1107/2009
	Bioaccumulation
	Long‐range transport
PBT	Persistence	Quinolin‐8‐ol is not considered to be a persistent, bioaccumulative and toxic (PBT) substance according to point 3.7.2 of Annex II of Regulation (EC) 1107/2009
	Bioaccumulation
	Toxicity
vPvB	Persistence	Quinolin‐8‐ol is not considered to be a very persistent, very bioaccumulative substance according to point 3.7.3 of Annex II of Regulation (EC) 1107/2009
	Bioaccumulation